The first-ever global guidelines for pregnancy in women with IBD were recently published in the Foundation’s Inflammatory Bowel Diseases journal. The guidelines say it’s safe to keep taking your biologic medications during pregnancy and breastfeeding and recommend talking with

No sé si habéis leído esto pero es la leche. Así, sin más.

Out Now! Aspergillus fumigatus dsRNA virus promotes fungal fitness and pathogenicity in the mammalian host bit.ly/45jAbD6 #AspergillusFumigatus #Mycovirus #FungalPathogenicity

Read a New article derived frontera the #ENEIDAregistry of GETECCU on New Insight into thiopurine toxicity kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

Gaining the Upper Hand – Upadacitinib for Crohn’s Disease with Ileostomy: A Real-World Gap Addressed. rdcu.be/eARJX . My invited commentary on doi.org/10.1007/s10620…, just published in Digestive Diseases and Sciences. Lauren Loeb, MD Francis (Frank) Farraye, MD, MSc Edward Loftus Jami Kinnucan, MD, FACG, AGAF, FCCF Jana G Hashash, MD, MSc

Absolutely delighted to see our book published - thanks to the co-editors Jacek Mostwin #ReneGenadry #SusanaMagalhaes and Springer Nature and #MariaGuiliaMarini Manuel Pera Julio Mayol BJS CLOSLER Dr. Alfredo Quiñones-Hinojosa Dr Ourania Varsou (She/Her) Gimbernat Surgical Society

Descansa en paz, presidente Javier Lambán. heraldo.es/noticias/arago…

Brilliant!!! Congrats, Syed! #Shackelfords

Escuchando a una magnífica soprano colombiana ⁦Fabi An E. Puentes M.⁩

The UK just joined the US, Canada and a few others in approving Teplizumab, which delays type 1 diabetes in those at high risk It's pretty effective, but it's the only approved therapy for type 1 diabetes prevention – so what else is in the pipeline? 🧵

Acabemos con el MITO. NO quitar la sal en la dieta hospitalaria!!!. Favorece la #desnutricion y además "Sodium supplementation with diuretics may improve kidney function, promote weight loss, and shorten length of hospital stay"

I left Mexico yesterday with good news through the grapevine and landed in Copenhagen to the FDA announcement that semaglutide injection to treat metabolic-associated steatohepatitis (MASH) was approved: fda.gov/drugs/news-eve… nature.com/articles/s4157… #LiverTwitter #SLDthinktank

Good drugs in Crohn's disease will improve symptoms (of course) but also actually reduce 'adverse events' Here, for example, Guselkumab (an IL23 blocker) reduced serious infections, even though it's immunosuppressive The adverse events aren't the drug – it's the inflammation

Important data for giving information for patients!!!

En el 3er. Simposio de #EII en el @HIC de Bucaramanga Colombia, nuestro presidente Dr. Fabián Juliao Baños, la Coordinadora del Grupo Joven Dra Viviana Parra y el Coordinador de RRSS Fabi An E. Puentes M. , entre otros, participando con conferencias para Médicos y Pacientes.

🚨 Big milestone in MASLD/MASH! We now have two FDA-approved drugs: 🔸 Resmetirom (oral, THR-β agonist) 🔹 Semaglutide (weekly SC, GLP-1 RA) I made this simple side-by-side comparison 👇

Semana Brasileña de Doencias Inflamatorias Intestinales!! #SEBRADII25 #IBD GADECCU presente! Gran evento…viejos y nuevos amigos!!

Costará mucho acabar con este mito, como muchos otros relacionados con la dieta. La cantidad de pseudociencia alrededor de ls nutrición es asombrosa. La desnutrición en el hospital no ha mejorado desde 1985 pubmed.ncbi.nlm.nih.gov/3927087/ thelancet.com/journals/lance…

Samuel Hume Especially in Crohn's, where a disease-related abscess gets classified as an infection - true, buuuut...disease-related and drug-related should be different categories...IMHO. Site PI should make the call.

La presidencia de PANCCO me dejó, además de conocer gente excelente de toda Latinoamérica, el convencimiento q el EMPODERAMIENTO de los pacientes es FUNDAMENTAL. Debemos enseñarlos a vivir con su EII y a tener buena ADHERENCIA al tratamiento.